American Rare Earths And 2 Additional ASX Penny Stocks To Watch

As the Australian market prepares for a potentially positive start to the week, investors are keeping a close eye on bond yields and global economic indicators. In this context, penny stocks—often smaller or newer companies—continue to attract attention due to their potential for significant growth when supported by strong financials. Despite being considered an outdated term by some, these stocks can offer unique opportunities for investors seeking value in under-the-radar firms with promising prospects.

Here we highlight a subset of our preferred stocks from the screener.

American Rare Earths (ASX:ARR)

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: American Rare Earths Limited, with a market cap of A$201 million, explores and develops mineral resources in the United States.

Operations: Currently, there are no reported revenue segments for the company.

Market Cap: A$201M

American Rare Earths Limited is currently a pre-revenue company with no significant revenue streams, focusing on the development of its Halleck Creek Rare Earths Project in Wyoming. Recent updates include an expanded Scoping Study for the Cowboy State Mine, projecting a larger operation with an after-tax NPV of approximately US$1.07 billion and initial capital needs around US$900 million. Despite stable weekly volatility and no shareholder dilution over the past year, challenges persist due to unprofitability and auditor concerns about its going concern status. The management team has limited tenure, though the board is experienced.

• Take a closer look at American Rare Earths' potential here in our financial health report.
• Gain insights into American Rare Earths' outlook and expected performance with our report on the company's earnings estimates.

Berkeley Energia (ASX:BKY)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Berkeley Energia Limited focuses on the exploration and development of mineral properties in Spain, with a market capitalization of A$365.96 million.

Operations: Currently, there are no revenue segments reported for Berkeley Energia.

Market Cap: A$365.96M

Berkeley Energia Limited, with a market cap of A$365.96 million, operates as a pre-revenue entity focused on mineral exploration in Spain. The company remains unprofitable, reporting an increased net loss of A$8.7 million for the year ending June 2026. Despite this, Berkeley is debt-free and has sufficient cash runway exceeding three years if current free cash flow trends persist. Recent board changes include the appointment of José Bogas Gálvez as an independent Non-Executive Director, bringing extensive experience from the Spanish energy sector to bolster strategic direction amidst ongoing volatility and challenges in profitability growth.

• Click here to discover the nuances of Berkeley Energia with our detailed analytical financial health report.
• Learn about Berkeley Energia's historical performance here.

Cogstate (ASX:CGS)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Cogstate Limited is a neuroscience solutions company focused on developing and commercializing digital brain health assessments globally, with a market cap of A$648.40 million.

Operations: The company's revenue is derived from two main segments: Healthcare, including sports-related services, which generated $2.50 million, and Clinical Trials, encompassing precision recruitment tools and research activities, contributing $58.37 million.

Market Cap: A$648.4M

Cogstate Limited, with a market cap of A$648.40 million, has demonstrated robust financial performance and strategic growth in the neuroscience sector. The company reported revenue of US$60.86 million for the fiscal year ending June 2026, driven by its Clinical Trials segment contributing significantly to its earnings. Cogstate remains debt-free, showcasing strong financial health with short-term assets exceeding both short and long-term liabilities. Recent developments include an annual dividend increase and positive revenue guidance for FY27, highlighting record contracted future revenues of US$118.5 million, enhancing earnings visibility amidst a stable management team and experienced board leadership.

• Click to explore a detailed breakdown of our findings in Cogstate's financial health report.
• Assess Cogstate's future earnings estimates with our detailed growth reports.

Seize The Opportunity

• Unlock our comprehensive list of 410 ASX Penny Stocks by clicking here.
• Contemplating Other Strategies? We've found 7 US stocks that are forecast to pay a dividend yeild of over 6% next year. See the full list for free.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com